0001415889-24-019905.txt : 20240722 0001415889-24-019905.hdr.sgml : 20240722 20240722201850 ACCESSION NUMBER: 0001415889-24-019905 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240718 FILED AS OF DATE: 20240722 DATE AS OF CHANGE: 20240722 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Aslan Fred CENTRAL INDEX KEY: 0001909362 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-42179 FILM NUMBER: 241132703 MAIL ADDRESS: STREET 1: C/O ARTIVA BIOTHERAPEUTICS, INC. STREET 2: 4747 EXECUTIVE DRIVE, SUITE 1150 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Artiva Biotherapeutics, Inc. CENTRAL INDEX KEY: 0001817241 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 863614316 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5505 MOREHOUSE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 267-4467 MAIL ADDRESS: STREET 1: 5505 MOREHOUSE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 form4-07232024_120741.xml X0508 4 2024-07-18 0001817241 Artiva Biotherapeutics, Inc. ARTV 0001909362 Aslan Fred C/O ARTIVA BIOTHERAPEUTICS, INC. 5505 MOREHOUSE DRIVE, SUITE 100 SAN DIEGO CA 92121 true true false false President and CEO 0 Common Stock 2024-07-22 4 A 0 228905 0 A 228905 D Employee Stock Option (Right to Buy) 12 2024-07-18 4 A 0 343811 0 A 2034-07-17 Common Stock 343811 343811 D Represents restricted stock unit award granted under the Issuer's 2024 Equity Incentive Plan. 25% of the shares will vest on July 19, 2025, and the remaining shares vest in 36 equal monthly installments thereafter. /s/ Neha Krishnamohan, Attorney-in-Fact 2024-07-22